Anthony Milnes Coates

Federated MDTA LLC (dba MDT Advisers) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1997 as HBSS Newco LLC. They are a subsidiary of Federated MDTA Trust, ultimately held by Federated Hermes, Inc. (NYSE: FHI) (formerly Federated Investors, Inc.). MDT Advisers provides investment advisory services to individual and institutional investors.

The Law Debenture Trust Company of New York, Inc. provides trust services. The company is headquartered in New York, NY.

Gasrec Ltd. engages in the provision of liquefied natural gas fuel for road transport in North West Europe. It offers solutions for natural gas vehicle users. The firm's natural gas vehicles include Mercedes CNG Sprinter, Iveco Daily Range, Iveco Rigid, Scania Rigid, and Mercedes Econic. The company was founded on July 23, 2003 and is headquartered in London, the United kingdom.

Allchurches Trust Ltd. provides charitable services. The firm promotes Christian religion by contributing to the funds of charitable institutions. The company was founded in 1972 and is headquartered in Gloucester, UK.

Babraham Bioscience Technologies Ltd. provides business research and consulting services. It also offers financial and administrative services to start-up biotech companies. The company was founded in 1996 and is located in Cambridge, UK

Ionix Pharmaceuticals Ltd. used to develop analgesic medicines for the treatment of acute and chronic pain. Its drugs were used for the treatment of pain associated with chronic debilitating diseases such as osteoarthritis, diabetes, cancer and multiple sclerosis. The company was founded by Andrew Sandham, Phillip J. Birch, John Wood and Ann Gail Hayes in 2001 and was located in Cambridge, UK.

Part of Pfizer Inc., Pharmacia AB /Hillerod Unit/ is a pharmaceutical company based in Hillerod, Sweden. Pharmacia AB /Hillerod Unit was acquired by Pharmacia AB /Hillerod UnitManagement/ on January 10, 2001.

Clarat Partners LLP (Clarat) is a specialist UK investment firm which was established by Barry Clare and David Karat in 2003 to facilitate private equity investments in healthcare assets. Based in London, Clarat aims to share their expertise, participate in sector and transaction evaluations and co-invest in attractive transactions in the healthcare, beauty, personal care and well-being sectors and to work with private equity firms and other investors who wish to become involved in these sectors or to increase their exposure to them.

J.P. Morgan Cazenove Ltd. (JPMC) is jointly owned by JPMorgan and Cazenove Group Ltd. Headquartered in London, JPMC has offices in Hong Kong, Beijing, Singapore, Frankfurt, Paris and New York as well as access to JPMorgan's global network. The firm provides a full range of investment banking services, including financial advice, M&A, investor relations, debt and equity capital markets advice and execution and equity research and distribution. The Equities business forms an important part of the Investment Banking division. JPMC analysts cover the major stocks in all areas of specialisation across the UK, Europe and Asia ex-Japan

Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.

Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden.

Part of Law Debenture Corp. Plc, L.D.C. Trust Management Ltd. provides fund trust services. The company is based in London, UK and was founded in 1975.

Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB.

The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020.

Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden.

PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015.

Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom.

Ananda Developments Plc engages in the provision of cannabinoid medicines for the treatment of complex, chronic inflammatory pain conditions. The company was founded on January 19, 2018, and is headquartered in London, the United Kingdom.

Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

The West London Synagogue of British Jews was founded in 1840 and is the oldest Reform synagogue in the UK. The West London Synagogue is located in London, UK, and has expanded its building in every generation, including classrooms for the children's Hebrew school, lecture halls and libraries, as well as offices for the Rabbis and the administrative staff. The synagogue was established to provide a place of worship for Jews who lived closer to the city center and to offer religious services with decorum, a sermon in English, and provision for the teaching of Hebrew and Judaism. The synagogue has grown over the years and now has over 3,000 members. It participates in many Jewish, non-Jewish, and interfaith activities and offers a wide range of family and communal events, music, lectures, and films.

EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021.

QuantalRF AG is an innovative RF semiconductor company based in Zurich, Switzerland, with R&D centers in the USA. The Swiss company is focused on developing novel quantal technologies for RF front-end module (FEM) and semiconductor manufacturer customers, as well as solutions for customers with specialized applications. The company's patented quantal technology is transforming the RF front-end with ultra-compact solutions in CMOS SOI technology, rivaling wave and GaAs performance for commercial broadband applications. The CEO of the company is Ali Fard.

Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden.